Cargando…
DNA/RNA heteroduplex oligonucleotides: An unanticipated twist in the delivery of ASOs
Autores principales: | Setten, Ryan L., Dowdy, Steven F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9256975/ https://www.ncbi.nlm.nih.gov/pubmed/35847172 http://dx.doi.org/10.1016/j.omtn.2022.06.013 |
Ejemplares similares
-
DNA/RNA heteroduplex oligonucleotide for highly efficient gene silencing
por: Nishina, Kazutaka, et al.
Publicado: (2015) -
DNA/RNA heteroduplex oligonucleotide technology for regulating lymphocytes in vivo
por: Ohyagi, Masaki, et al.
Publicado: (2021) -
Highly efficient silencing of microRNA by heteroduplex oligonucleotides
por: Yoshioka, Kotaro, et al.
Publicado: (2019) -
Short DNA/RNA heteroduplex oligonucleotide interacting proteins are key regulators of target gene silencing
por: Asada, Ken, et al.
Publicado: (2021) -
Artificial cationic oligosaccharides for heteroduplex oligonucleotide-type drugs
por: Hara, Rintaro Iwata, et al.
Publicado: (2018)